Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parkinson's Disease With Mild Cognitive Impairment Treated With Nicotinic Agonist Drug

NCT04810104 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT04810104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04810104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parkinson's Disease With Mild Cognitive Impairment Treated With Nicotinic Agonist Drug
Lead sponsor
King's College London
Phase
Phase 2
Overall status
Withdrawn
Start date
October 31, 2022
Completion date
April 30, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment, parkinson disease